159 related articles for article (PubMed ID: 34299359)
1. Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis.
Pandolfi L; Marengo A; Japiassu KB; Frangipane V; Tsapis N; Bincoletto V; Codullo V; Bozzini S; Morosini M; Lettieri S; Vertui V; Piloni D; Arpicco S; Fattal E; Meloni F
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299359
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells.
Pandolfi L; Frangipane V; Bocca C; Marengo A; Tarro Genta E; Bozzini S; Morosini M; D'Amato M; Vitulo S; Monti M; Comolli G; Scupoli MT; Fattal E; Arpicco S; Meloni F
Molecules; 2019 Sep; 24(18):. PubMed ID: 31509965
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice.
González-Sánchez E; Muñoz-Callejas A; Gómez-Román J; San Antonio E; Marengo A; Tsapis N; Bohne-Japiassu K; González-Tajuelo R; Pereda S; García-Pérez J; Cavagna L; González-Gay MÁ; Vicente-Rabaneda EF; Meloni F; Fattal E; Castañeda S; Urzainqui A
Br J Pharmacol; 2022 Sep; 179(18):4534-4548. PubMed ID: 35726496
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus.
Chiesa E; Dorati R; Conti B; Modena T; Cova E; Meloni F; Genta I
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087241
[TBL] [Abstract][Full Text] [Related]
5. Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.
Codullo V; Cova E; Pandolfi L; Breda S; Morosini M; Frangipane V; Malatesta M; Calderan L; Cagnone M; Pacini C; Cavagna L; Recalde H; Distler JHW; Giustra M; Prosperi D; Colombo M; Meloni F; Montecucco C
J Control Release; 2019 Sep; 310():198-208. PubMed ID: 31430501
[TBL] [Abstract][Full Text] [Related]
6. Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs.
Almeida APB; Damaceno GBR; Carneiro AF; Bohr A; Gonçalves HR; Valadares MC; Nascimento TL; Lima EM
J Biomater Appl; 2019 Nov; 34(5):617-630. PubMed ID: 31357900
[No Abstract] [Full Text] [Related]
7. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
8. Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis.
Togami K; Maruta Y; Nanbu M; Tada H; Chono S
Drug Dev Ind Pharm; 2020 Nov; 46(11):1873-1880. PubMed ID: 32940095
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic Acid Surface Modified Liposomes Prepared via Orthogonal Aminoxy Coupling: Synthesis of Nontoxic Aminoxylipids Based on Symmetrically α-Branched Fatty Acids, Preparation of Liposomes by Microfluidic Mixing, and Targeting to Cancer Cells Expressing CD44.
Bartheldyová E; Effenberg R; Mašek J; Procházka L; Knötigová PT; Kulich P; Hubatka F; Velínská K; Zelníčková J; Zouharová D; Fojtíková M; Hrebík D; Plevka P; Mikulík R; Miller AD; Macaulay S; Zyka D; Drož L; Raška M; Ledvina M; Turánek J
Bioconjug Chem; 2018 Jul; 29(7):2343-2356. PubMed ID: 29898364
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells.
Cannito S; Bincoletto V; Turato C; Pontisso P; Scupoli MT; Ailuno G; Andreana I; Stella B; Arpicco S; Bocca C
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164326
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-conjugated liposomes loaded with dexamethasone: A promising approach for the treatment of inflammatory diseases.
Bohne Japiassu K; Fay F; Marengo A; Mendanha SA; Cailleau C; Louaguenouni Y; Wang Q; Denis S; Tsapis N; Leite Nascimento T; Martins Lima E; Fattal E
Int J Pharm; 2023 May; 639():122946. PubMed ID: 37044230
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes.
Otsuka M; Shiratori M; Chiba H; Kuronuma K; Sato Y; Niitsu Y; Takahashi H
Exp Lung Res; 2017; 43(6-7):271-282. PubMed ID: 29035148
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.
Quagliariello V; Iaffaioli RV; Armenia E; Clemente O; Barbarisi M; Nasti G; Berretta M; Ottaiano A; Barbarisi A
J Cell Physiol; 2017 Aug; 232(8):2063-2074. PubMed ID: 27607841
[TBL] [Abstract][Full Text] [Related]
14. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
15. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
16. Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease.
Xiao H; Zhang GF; Liao XP; Li XJ; Zhang J; Lin H; Chen Z; Zhang X
Int J Rheum Dis; 2018 Feb; 21(2):477-486. PubMed ID: 29316328
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the mechanism involved in bleomycin-induced increased hyaluronan production in rat lung.
Teder P; Nettelbladt O; Heldin P
Am J Respir Cell Mol Biol; 1995 Feb; 12(2):181-9. PubMed ID: 7532420
[TBL] [Abstract][Full Text] [Related]
19. Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatory.
Bozzini S; Della Zoppa M; Bagnera C; Bozza E; Croce S; Valsecchi C; Belliato M; Pandolfi L; Morbini P; Comoli P; Avanzini MA; Meloni F
Biomed Pharmacother; 2023 Jun; 162():114640. PubMed ID: 37004325
[TBL] [Abstract][Full Text] [Related]
20. Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes.
Japiassu KB; Fay F; Marengo A; Louaguenouni Y; Cailleau C; Denis S; Chapron D; Tsapis N; Nascimento TL; Lima EM; Fattal E
J Control Release; 2022 Dec; 352():15-24. PubMed ID: 36209941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
